Kailera Therapeutics, Inc. KLRA
12.26 USD -0.54 (-4.26%)
Nov 5, 2026, 1:22 PM EST
11.93 Day range 13.30
9.76 52-week range 28.23
- YTD
- -52.87%
- 1 year
- -52.87%
Analyst view
Price target (mean) 42.75 +248.8% upside
Now 12.26
- Target (low)
- 30.00
- Target (mean)
- 42.75
- Target (high)
- 57.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.01 | -1.30 – -0.79 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Next quarter | -1.16 | -1.54 – -0.95 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Current year | -4.10 | -5.86 – -2.96 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Next year | -4.30 | -5.89 – -2.99 | -4.10 | -4.9% | 0 | 0.0% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 12, 2026 | Leerink Partners | Initiated | — | Outperform |
| May 12, 2026 | Jefferies | Initiated | — | Buy |
| May 12, 2026 | Evercore ISI Group | Initiated | — | Outperform |
| May 12, 2026 | JP Morgan | Initiated | — | Overweight |